Pluri Inc

NASDAQ:PLUR 3:50:24 PM EDT

0.80

-0.02 (-2.85%)

Pluri Inc Stock, NASDAQ:PLUR

MATAM Advanced Technology Park, Building No. 5, Haifa, Haifa 3508409

United States of America

Phone: +972.74.710.8600

Number of Employees: 154

http://www.pluri-biotech.com

Description

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.